Impact of preoperative immunosuppressive agents on postoperative outcomes in Crohn’s disease

High Impact Factor (IF > 5) — 14 citations

1. GW Moran, M Gordon, V Sinopolou, SJ Radford…. British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025. Gut. 2025. doi:10.1136/flgastro-2025-103425.

   IF 26.2PDF
2. CA Lamb, NA Kennedy, T Raine, PA Hendy, PJ Smith…. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019. doi:10.1136/gutjnl-2019-318484corr1 PMID:33674339.

   IF 26.2PDF
3. BL Cohen, P Fleshner, SV Kane, HH Herfarth…. Prospective cohort study to investigate the safety of preoperative tumor necrosis factor inhibitor exposure in patients with inflammatory bowel disease undergoing intra …. Gastroenterology. 2022. doi:10.1053/j.gastro.2022.03.057 PMID:35413359.

   IF 25.9PDF
4. PL Stoner, A Kamel, F Ayoub, S Tan…. Perioperative care of patients with inflammatory bowel disease: focus on nutritional support. Gastroenterology …. 2018. doi:10.1155/2018/7890161 PMID:30344603.

   IF 25.9PDF
5. M Aziz, H Haghbin, S Sharma, R Fatima…. Safety of bariatric surgery in patients with inflammatory bowel disease: A systematic review and meta‐analysis. Clinical …. 2020. doi:10.1007/s11695-020-04729-4.

   IF 12.2PDF
6. CCY Law, C Bell, D Koh, Y Bao…. Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease. Cochrane Database …. 2020. doi:10.1093/ibd/izaa020.

   IF 9.4PDF
7. Y Li, L Stocchi, B Shen, X Liu…. Salvage surgery after failure of endoscopic balloon dilatation versus surgery first for ileocolonic anastomotic stricture due to recurrent Crohn's disease. Journal of British …. 2015. doi:10.1002/bjs.9906.

   IF 8.8PDF
8. S Sebastian, JP Segal, C Hedin…. ECCO topical review: roadmap to optimal peri-operative care in IBD. Journal of Crohn's …. 2023.

   IF 8.7PDF
9. A El-Hussuna, P Myrelid, SD Holubar…. Biological treatment and the potential risk of adverse postoperative outcome in patients with inflammatory bowel disease: an open-source expert panel review of the …. Crohn's & Colitis …. 2019. doi:10.1093/ecco-jcc/jjz203.808.

   IF 8.7PDF
10. AL Lightner, F Grass, A Alsughayer…. Postoperative outcomes in ustekinumab-treated patients undergoing abdominal operations for Crohn's disease: single-center series. Crohn's & Colitis …. 2019. doi:10.1093/crocol/otz018.

    IF 8.7PDF
11. W Huang, Y Tang, L Nong, Y Sun. Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: a meta-analysis of observational studies. Journal of Crohn's and Colitis. 2015. doi:10.1093/ecco-jcc/jju028.

    IF 8.7PDF
12. P Waterland, T Athanasiou…. Post-operative abdominal complications in Crohn's disease in the biological era: systematic review and meta-analysis. World Journal of …. 2016. doi:10.4240/wjgs.v8.i3.274 PMID:27022455.

    IF 5.8PDF
13. A Al-Janabi, ZZN Yiu. Biologics in psoriasis: updated perspectives on long-term safety and risk management. Psoriasis: Targets and Therapy. 2022. doi:10.2147/ptt.s328575.

    IF 5.7PDF
14. S Zhang, Y Cao, Z Wang, H Liu, Y Teng, G Li, J Liu…. Fermented Sargassum fusiforme Mitigates Ulcerative Colitis in Mice by Regulating the Intestinal Barrier, Oxidative Stress, and the NF-κB Pathway. Foods. 2023. doi:10.3390/foods12101928 PMID:37238746.

    IF 5.1PDF